MEP18508A - Pharmaceutical composition and preparation thereof - Google Patents

Pharmaceutical composition and preparation thereof

Info

Publication number: MEP18508A
Authority: ME; Montenegro
Prior art keywords: pharmaceutical composition; preparation; active ingredient; additional active; admixture
Prior art date: 1999-07-28

Application number

MEP-185/08A

Other languages

Bosnian (bs)

English (en)

Croatian (hr)

Inventor

Morvai Magdolna Vitanyine

Peterne Kovacs

Mathe Irma Kalmanne

Boglarka Jakab

Erzsebet Vegeli

Original Assignee

Chinoin Gyogyszer Es Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-28

Filing date

2000-07-28

Publication date

2010-06-10

2000-07-28 Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet

2010-06-10 Publication of MEP18508A publication Critical patent/MEP18508A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 3
DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 abstract 1
CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 abstract 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
229960004415 codeine phosphate Drugs 0.000 abstract 1
OMFNSKIUKYOYRG-MOSHPQCFSA-N drotaverine Chemical compound C1=C(OCC)C(OCC)=CC=C1\C=C/1C2=CC(OCC)=C(OCC)C=C2CCN\1 OMFNSKIUKYOYRG-MOSHPQCFSA-N 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
235000005985 organic acids Nutrition 0.000 abstract 1
229960005489 paracetamol Drugs 0.000 abstract 1
229940069338 potassium sorbate Drugs 0.000 abstract 1
235000010241 potassium sorbate Nutrition 0.000 abstract 1
239000004302 potassium sorbate Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

MEP-185/08A 1999-07-28 2000-07-28 Pharmaceutical composition and preparation thereof MEP18508A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HU9902559A HU225779B1 (en)	1999-07-28	1999-07-28	Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
PCT/HU2000/000086 WO2001007024A2 (en)	1999-07-28	2000-07-28	Paracetamol and drotaverine containing composition
YUP-61/02A RS50074B (sr)	1999-07-28	2000-07-28	Farmaceutski preparat koji sadrži paracetamol i drotaverin

Publications (1)

Publication Number	Publication Date
MEP18508A true MEP18508A (en)	2010-06-10

Family

ID=90014235

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
MEP-185/08A MEP18508A (en)	1999-07-28	2000-07-28	Pharmaceutical composition and preparation thereof
MEP-2008-185A ME00088B (me)	1999-07-28	2000-07-28	Farmaceutski preparat i njegova priprema

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
MEP-2008-185A ME00088B (me)	1999-07-28	2000-07-28	Farmaceutski preparat i njegova priprema

Country Status (19)

Country	Link
EP (1)	EP1200088B1 (pl)
AT (1)	ATE241983T1 (pl)
AU (1)	AU6308800A (pl)
BG (1)	BG65553B1 (pl)
DE (1)	DE60003188T2 (pl)
DK (1)	DK1200088T3 (pl)
EA (1)	EA003779B1 (pl)
EE (1)	EE04952B1 (pl)
ES (1)	ES2197107T3 (pl)
GE (1)	GEP20053581B (pl)
HR (1)	HRP20020071B1 (pl)
HU (1)	HU225779B1 (pl)
ME (2)	MEP18508A (pl)
PL (1)	PL197749B1 (pl)
PT (1)	PT1200088E (pl)
RS (1)	RS50074B (pl)
SI (1)	SI1200088T1 (pl)
UA (1)	UA72535C2 (pl)
WO (1)	WO2001007024A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2232018C2 (ru) *	2002-10-09	2004-07-10	Открытое акционерное общество "Ирбитский химико-фармацевтический завод"	Спазмолитическое лекарственное средство
RU2252024C2 (ru) *	2003-04-22	2005-05-20	Гаврилов Андрей Станиславович	Способ получения спазмолитического лекарственного средства
UY29527A1 (es)	2005-05-13	2006-12-29	Schering Ag	Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
WO2016075617A1 (en) *	2014-11-11	2016-05-19	Dr. Reddys Laboratories Limited	Fixed dose pharmaceutical formulations of analgesic and anti-spasmodic drugs
EP3520781A1 (en) *	2018-02-05	2019-08-07	Adamed sp. z o.o.	A pharmaceutical composition comprising metamizole, drotaverine, and caffeine
CR20220506A (es) *	2020-03-09	2023-01-17	Sushma Paul Berlia	Formulaciones de liberación controlada que comprenden drotaverina o sal de la misma
WO2021213455A1 (zh) *	2020-04-23	2021-10-28	浙江养生堂天然药物研究所有限公司	药物组合及其用途
BG113694A (bg)	2023-04-26	2024-10-31	"Адифарм" Еад	Фармацевтичен състав под формата на таблетка, съдържаща метамизол, кофеин и дротаверин и метод за нейното получаване
PL451289A1 (pl) *	2025-02-25	2026-04-13	Pikralida Spółka Z Ograniczoną Odpowiedzialnością	Kompozycja farmaceutyczna zawierająca naproksen i drotawerynę lub ich farmaceutycznie dopuszczalne sole, sposób jej wytwarzania oraz jej zastosowanie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3830353A1 (de) *	1988-09-07	1990-03-15	Basf Ag	Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US5348745A (en) *	1989-05-09	1994-09-20	Miles Inc.	Aqueous granulation solution and a method of tablet granulation

1999
- 1999-07-28 HU HU9902559A patent/HU225779B1/hu not_active IP Right Cessation
2000
- 2000-07-28 UA UA2002021475A patent/UA72535C2/uk unknown
- 2000-07-28 SI SI200030163T patent/SI1200088T1/xx unknown
- 2000-07-28 GE GE4754A patent/GEP20053581B/en unknown
- 2000-07-28 WO PCT/HU2000/000086 patent/WO2001007024A2/en not_active Ceased
- 2000-07-28 RS YUP-61/02A patent/RS50074B/sr unknown
- 2000-07-28 ME MEP-185/08A patent/MEP18508A/xx unknown
- 2000-07-28 EE EEP200200042A patent/EE04952B1/xx not_active IP Right Cessation
- 2000-07-28 EA EA200200211A patent/EA003779B1/ru not_active IP Right Cessation
- 2000-07-28 ES ES00949829T patent/ES2197107T3/es not_active Expired - Lifetime
- 2000-07-28 EP EP00949829A patent/EP1200088B1/en not_active Expired - Lifetime
- 2000-07-28 DK DK00949829T patent/DK1200088T3/da active
- 2000-07-28 ME MEP-2008-185A patent/ME00088B/me unknown
- 2000-07-28 AT AT00949829T patent/ATE241983T1/de active
- 2000-07-28 PT PT00949829T patent/PT1200088E/pt unknown
- 2000-07-28 DE DE60003188T patent/DE60003188T2/de not_active Expired - Lifetime
- 2000-07-28 PL PL353209A patent/PL197749B1/pl unknown
- 2000-07-28 HR HR20020071A patent/HRP20020071B1/xx not_active IP Right Cessation
- 2000-07-28 AU AU63088/00A patent/AU6308800A/en not_active Abandoned
2002
- 2002-01-30 BG BG106368A patent/BG65553B1/bg unknown

Also Published As

Publication number	Publication date
HRP20020071A2 (en)	2003-12-31
EE200200042A (et)	2003-04-15
EP1200088A2 (en)	2002-05-02
HUP9902559A2 (hu)	2002-04-29
SI1200088T1 (en)	2003-12-31
ATE241983T1 (de)	2003-06-15
BG65553B1 (bg)	2008-12-30
YU6102A (sh)	2005-03-15
BG106368A (en)	2002-08-30
RS50074B (sr)	2009-01-22
PT1200088E (pt)	2003-10-31
DE60003188D1 (de)	2003-07-10
EA003779B1 (ru)	2003-08-28
HUP9902559D0 (en)	1999-10-28
UA72535C2 (en)	2005-03-15
ME00088B (me)	2010-10-10
WO2001007024A2 (en)	2001-02-01
DE60003188T2 (de)	2004-07-01
HRP20020071B1 (hr)	2011-01-31
PL197749B1 (pl)	2008-04-30
AU6308800A (en)	2001-02-13
EA200200211A1 (ru)	2002-08-29
PL353209A1 (pl)	2003-11-03
HUP9902559A3 (en)	2003-05-28
ES2197107T3 (es)	2004-01-01
EP1200088B1 (en)	2003-06-04
HU225779B1 (en)	2007-08-28
WO2001007024A3 (en)	2001-03-29
GEP20053581B (en)	2005-07-25
DK1200088T3 (da)	2003-09-22
EE04952B1 (et)	2008-02-15

Similar Documents

Publication	Publication Date	Title
NO2025027I1 (no)	2025-06-13	Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
EE201000018A (et)	2010-04-15	Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
EP1100522A4 (en)	2003-01-08	ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
ATE362314T1 (de)	2007-06-15	Herbizidzusammensetzungen umfassend imidazolinonsäure
NO20016107L (no)	2002-02-11	Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
DK1157037T3 (da)	2003-11-24	GCSF-konjugater
EP1247456A3 (en)	2003-12-10	Palatable pharmaceutical compositions for companion animals
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
ITMI20022292A1 (it)	2004-04-30	9a-azalidi ad attivita' antiinfiammatoria.
MEP18508A (en)	2010-06-10	Pharmaceutical composition and preparation thereof
IT1230703B (it)	1991-10-29	Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
IT8721538A0 (it)	1987-07-31	Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
YU12397A (en)	1999-11-22	NOVEL PYRIMIDO [1,2-a] INDOLES
FI853228A7 (fi)	1986-02-25	Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.
TR200003451T2 (tr)	2001-04-20	Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
PT1358159E (pt)	2009-10-27	Tartrato e fosfato de 3,4 diaminopiridina, as suas composições farmacêuticas e as suas utilizações
DE60303149D1 (de)	2006-03-30	Salz von morphin-6-glucuronid
ATE321530T1 (de)	2006-04-15	Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
BRPI0414319A (pt)	2006-11-07	agentes antibacterianos de quinolona
PT1299114E (pt)	2005-11-30	Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
WO2002002087A3 (de)	2002-06-20	Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii
DE60121142D1 (de)	2006-08-10	Zusammensetzung die paracetamol und niflumic säure enthält
BR0215498A (pt)	2004-12-28	Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes
IT8519204A0 (it)	1985-01-23	Composti ad attivita' mucolitica e broncodilatatrice, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono come principi attivi.
IT8521917A0 (it)	1985-08-12	Composti ad attivita' antispastica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono come principi attivi.